<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Advaxis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of cancer. Our goal is to develop cancer immunotherapies that teach the body to recognize tumors as a threat and do so in a way that minimizes side effects associated with traditional chemotherapy and radiation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth A. Berlin
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    iRadimed Corporation

    iRadimed Corporation

    IRADIMED CORPORATION is a leader in the development of innovative magnetic resonan...

    IRADIMED CORPORATION is a leader in the develop...

    Filing Type:    PU
    DiaMedica Therapeutics Inc.

    DiaMedica Therapeutics Inc.

    DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused ...

    DiaMedica Therapeutics Inc. is a clinical stage...

    Filing Type:    PU
    HeartIn, Inc

    HeartIn, Inc

    Founded in 2014 in Miami, Florida, HeartIn Inc. is constantly driving innovations ...

    Founded in 2014 in Miami, Florida, HeartIn Inc....

    Amount Raised:    $18,137.00
    Fundraising Status:    EC
    Filing Type:    CF
    Krystal Biotech, Inc.

    Krystal Biotech, Inc.

    We are a gene therapy company dedicated to developing and commercializing novel tr...

    We are a gene therapy company dedicated to deve...

    Filing Type:    PU
    Celldex Therapeutics, Inc.

    Celldex Therapeutics, Inc.

    Celldex is developing targeted therapeutics to address devastating diseases for wh...

    Celldex is developing targeted therapeutics to ...

    Filing Type:    PU
    DBV Technologies S.A.

    DBV Technologies S.A.

    DBV Technologies is developing ViaskinÂŽ, an investigational proprietary technolog...

    DBV Technologies is developing ViaskinÂŽ, an in...

    Filing Type:    PU
    NextCure, Inc.

    NextCure, Inc.

    NextCure is a clinical-stage biopharmaceutical company committed to discovering an...

    NextCure is a clinical-stage biopharmaceutical ...

    Filing Type:    PU
    Rubius Therapeutics, Inc.

    Rubius Therapeutics, Inc.

    Rubius Therapeutics developed our proprietary RED PLATFORMÂŽ to generate red blood...

    Rubius Therapeutics developed our proprietary R...

    Filing Type:    PU
    PDS Biotechnology Corporation

    PDS Biotechnology Corporation

    PDS Biotechnology has a growing pipeline of clinical-stage immunotherapies to trea...

    PDS Biotechnology has a growing pipeline of cli...

    Filing Type:    PU
    Sierra Oncology, Inc.

    Sierra Oncology, Inc.

    Sierra Oncology is a clinical stage drug development company advancing targeted th...

    Sierra Oncology is a clinical stage drug develo...

    Filing Type:    PU
    Precipio, Inc.

    Precipio, Inc.

    Precipio has built a platform designed to eradicate the problem of misdiagnosis by...

    Precipio has built a platform designed to eradi...

    Filing Type:    PU
    Tocagen Inc.

    Tocagen Inc.

    Tocagen is a clinical-stage, cancer-selective gene therapy company developing firs...

    Tocagen is a clinical-stage, cancer-selective g...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.